Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Email alerts
Commentary/Editorials
Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?
Robert J
Canter
,
Sean J
Judge
,
Craig P
Collins
,
Daniel Jaeho
Yoon
,
William J
Murphy
Journal for ImmunoTherapy of Cancer
Mar 2024,
12
(3)
e008443;
DOI:
10.1136/jitc-2023-008443
Key role of CD4+ T cells in determining CD8 function during CAR-T cell manufacture
J Joseph
Melenhorst
,
Beatriz C
Oliveira
Journal for ImmunoTherapy of Cancer
Mar 2024,
12
(3)
e008723;
DOI:
10.1136/jitc-2023-008723
Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel
Amanda A
Myers
,
Ashish M
Kamat
,
Angela
Kilbert
,
Matthew D
Galsky
Journal for ImmunoTherapy of Cancer
Feb 2024,
12
(2)
e008508;
DOI:
10.1136/jitc-2023-008508
CARs are sharpening their weapons
Alice
Pievani
,
Marta
Biondi
,
Sarah
Tettamanti
,
Andrea
Biondi
,
Gianpietro
Dotti
,
Marta
Serafini
Journal for ImmunoTherapy of Cancer
Jan 2024,
12
(1)
e008275;
DOI:
10.1136/jitc-2023-008275
Perspectives on imaging and immunotherapy: a review series
Elisabeth GE
de Vries
,
Lawrence H
Schwartz
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e005006;
DOI:
10.1136/jitc-2022-005006
Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research
Marco
Palla
,
Luigi
Scarpato
,
Rossella
Di Trolio
,
Paolo Antonio
Ascierto
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e004397;
DOI:
10.1136/jitc-2021-004397
Resistance to systemic immune checkpoint inhibition in the peritoneal niche
Daryl Kai Ann
Chia
,
Yong Xiang
Gwee
,
Raghav
Sundar
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e004749;
DOI:
10.1136/jitc-2022-004749
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Hussein A
Tawbi
,
Ryan J
Sullivan
,
David
Feltquate
,
Theresa
LaVallee
,
Naiyer A
Rizvi
,
Elad
Sharon
,
Jeffrey
Sosman
,
Harriet M
Kluger
Journal for ImmunoTherapy of Cancer
Jul 2023,
11
(7)
e007309;
DOI:
10.1136/jitc-2023-007309
Gasdermin-mediated pyroptosis confers anticancer immunity
Wu
Lin
,
Ben
Lin
,
Quan
Zhou
,
Lisong
Teng
Journal for ImmunoTherapy of Cancer
Jan 2024,
12
(1)
e008162;
DOI:
10.1136/jitc-2023-008162
Commentary on oncolytic viruses: past, present, and future
Christopher
Larson
,
Bryan
Oronsky
,
Tony R
Reid
Journal for ImmunoTherapy of Cancer
Dec 2023,
11
(12)
e007905;
DOI:
10.1136/jitc-2023-007905
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
Special collections
COVID-19
(46)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(576)
Cancer Immunotherapy in Understudied Populations
(3)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(1010)
Commentary/Editorials
(158)
Computational I-O
(5)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(48)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(252)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(454)
Liquid Biopsies
(8)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(152)
Reviews
(248)
SITC 40th Anniversary: I-O Progress and Potential
(1)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(6536)
Press releases
(4)